iifl-logo-icon 1

Eiko Lifesciences Ltd Share Price

48.37
(2.81%)
Jul 3, 2024|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open48.2
  • Day's High49.49
  • 52 Wk High81.32
  • Prev. Close47.05
  • Day's Low47.2
  • 52 Wk Low45.1
  • Turnover (lac)25.76
  • P/E79.3
  • Face Value10
  • Book Value40.44
  • EPS0.61
  • Mkt. Cap (Cr.)60.07
  • Div. Yield0
No Records Found

Eiko Lifesciences Ltd KEY RATIOS

Sector

Chemicals

CMP
as on 03 Jul, 2024 12:00:00 AM

48.37 -2.81 -1.32

Open

48.2

Prev. Close

47.05

Turnover(Lac.)

25.76

Day's High

49.49

Day's Low

47.2

52 Week's High

81.32

52 Week's Low

45.1

Book Value

40.44

Face Value

10

Mkt Cap (₹ Cr.)

60.07

P/E

79.3

EPS

0.61

Divi. Yield

0

Eiko Lifesciences Ltd Corporate Action

30 Aug 2023

12:00 AM

AGM

Announcement Date: 30 Aug, 2023

arrow

6 May 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

30 Jun 2023

12:00 AM

Rights

arrow

Eiko Lifesciences Ltd NEWS AND UPDATE

No data found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Eiko Lifesciences Ltd SHAREHOLDING SNAPSHOT

03 Jul, 2024|11:53 PM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 24.23%

Foreign: 0.00%

Indian: 24.23%

Non-Promoter- 75.76%

Institutions: 0.00%

Non-Institutions: 75.76%

Custodian: 0.00%

Share Price

Eiko Lifesciences Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Loading...
Y/e 31 Mar( In .Cr)Mar-2023Mar-2022Mar-2021Mar-2020

Equity Capital

8.32

8.32

10.16

3.82

Preference Capital

0

0

0

0

Reserves

21.11

20.31

2.37

1.66

Net Worth

29.43

28.63

12.53

5.48

Minority Interest

View Balance Sheet
Loading...
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2016Mar-2015

Revenue

25.41

11.99

0

0

yoy growth (%)

111.93

0

0

0

Raw materials

-22.58

-10.61

0

0

As % of sales

88.86

88.5

0

0

Employee costs

-0.27

-0.11

0

0

View Profit & Loss
Loading...
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2016Mar-2015

Profit before tax

0.94

0.83

0

0

Depreciation

-0.56

-0.06

0

0

Tax paid

-0.23

-0.21

0

0

Working capital

2.57

7.66

0.67

0.07

Other operating items

View Cash Flow
Loading...
Y/e 31 MarMar-2022Mar-2021Mar-2016Mar-2015

Growth matrix (%)

Revenue growth

111.93

0

0

0

Op profit growth

148.21

0

0

0

EBIT growth

52.76

0

0

0

Net profit growth

14.87

0

0

0

View Ratios
Particulars (Rupees in Crores.)Mar-2020Mar-2019Mar-2018

Gross Sales

10.35

4.25

2.34

Excise Duty

0

0

0

Net Sales

10.35

4.25

2.34

Other Operating Income

0

0

0

Other Income

0.06

0.06

0.06

Eiko Lifesciences Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Pidilite Industries Ltd

PIDILITIND

3,119.75

87.481,56,921.24354.320.522,588.88163.92

Linde India Ltd

LINDEINDIA

8,501.9

169.7572,365.62104.330630.07402.73

SRF Ltd

SRF

2,386.1

51.8170,989.3437.10.32,857.61353.96

Deepak Nitrite Ltd

DEEPAKNTR

2,667.55

98.3636,611.98115.680.28671.15216.61

Gujarat Fluorochemicals Ltd

FLUOROCHEM

3,255

84.835,510.6686.010.091,043.2539.16

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Eiko Lifesciences Ltd

Management

Register Office

Registrar Office

Chairman & Non Executive Dir.

Laxmikant Kabra

Non-Exec & Non-Independent Dir

Bhavesh Dhirajlal Tanna

Independent Non Exe. Director

Rajkumar K Baheti

Independent Non Exe. Director

Mandkar Kamalakar Patil

Independent Non Exe. Director

Kajal Dhanpatraj Kothari

Whole-time Director

Umesh Ravindranath More

Company Sec. & Compli. Officer

Chintan Doshi

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

The Company was originally incorporated on 7th January 1977, under the name Narendra Investments (Delhi) Limited. Later, the Company changed its name from Narendra Investments (Delhi) Limited to Eiko LifeSciences Limited effective from 24 June 2021. The company commenced the new business activity primarily in manufacturing of speciality and fine chemicals.
Read More

Company FAQs

What is the Eiko Lifesciences Ltd share price today?

Down Arrow

The Eiko Lifesciences Ltd shares price on nse is Rs.₹48.37 today.

What is the Market Cap of Eiko Lifesciences Ltd?

Down Arrow

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Eiko Lifesciences Ltd is ₹60.07 Cr. as of 03 Jul ‘24

What is the PE and PB ratio of Eiko Lifesciences Ltd?

Down Arrow

The PE and PB ratios of Eiko Lifesciences Ltd is 79.3 and 1.20 as of 03 Jul ‘24

What is the 52 Week High and Low of Eiko Lifesciences Ltd?

Down Arrow

The 52-week high/low is the highest and lowest price at which a Eiko Lifesciences Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Eiko Lifesciences Ltd is ₹45.1 and ₹81.32 as of 03 Jul ‘24

What is the CAGR of Eiko Lifesciences Ltd?

Down Arrow

Eiko Lifesciences Ltd's CAGR for 5 Years at 8.50%, 3 Years at -7.79%, 1 Year at -21.20%, 6 Month at -24.49%, 3 Month at -15.33% and 1 Month at -5.47%.

What is the shareholding pattern of Eiko Lifesciences Ltd?

Down Arrow

The shareholding pattern of Eiko Lifesciences Ltd is as follows:
Promoters - 24.23 %
Institutions - 0.00 %
Public - 75.77 %

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.